• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medications during breastfeeding and pregnancy is a challenge for women suffering from the condition. There aren't enough data regarding how exposure over time may affect a fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological developmental conditions like impaired vision or hearing seizures, febrile seizures or IQ impairment. The authors acknowledge the need for higher-quality studies.

Risk/Benefit Analysis

Women who are pregnant and take Adhd Depression medication medication must weigh the benefits of taking it against the possible dangers for the baby. The doctors don't have the information to provide clear recommendations however they can provide information on the risks and benefits to aid pregnant women in making an informed decision.

A study published in Molecular Psychiatry found that women who used ADHD medications during their early pregnancy did not have a significantly increased risk of fetal heart malformations or major structural birth defects. Researchers used a vast, population-based case-control study to determine the prevalence cost of adhd medication uk major structural birth defects in babies born to mothers who had taken stimulants during the early stages of pregnancy and those who had not. Clinical geneticists, pediatric cardiologists and other experts reviewed the cases in order to ensure that the classification was accurate and to minimize any bias.

The study of the researchers had some limitations. Researchers were unable, in the first place, to separate the effects triggered by the medication from the disorder. This limitation makes it difficult to know whether the limited associations observed in the exposed groups are due to the use of medication or confounding by comorbidities. Additionally, the researchers did not look at the long-term effects of offspring on their parents.

The study did reveal that infants whose mothers took ADHD medication during pregnancy were at slightly more risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or cut back on their medications prior to or during pregnancy. The reason for this was central nervous system-related disorders and the increased risk for admission did not appear to be influenced by the stimulant medications were taken during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher chance of having an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These risks did not appear to be affected by the kind of medication used during pregnancy.

The researchers suggest that the small risk associated with the use of ADHD medications during early pregnancy may be offset by the greater benefits for both mother and child of continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, when they are able, assist them in developing strategies for improving their coping skills that can lessen the effects of her disorder on her daily functioning and relationships.

Medication Interactions

More and more doctors are confronted with the dilemma of whether to continue treatment or stop it during pregnancy as more women are diagnosed with ADHD. Often, these decisions are made in the absence of clear and authoritative evidence regardless, so doctors have to weigh their experience about their experiences, the experiences of other doctors, and what the research suggests about the subject as well as their own best judgment for each patient.

Particularly, the subject of potential risks for the infant can be difficult. Many studies on this subject are based on observational data instead of controlled research and their findings are often contradictory. Furthermore, most studies restrict their analysis to live births, which could underestimate severe teratogenic effects that cause abortion or termination of the pregnancy. The study discussed in the journal club addresses these limitations, by examining both information on deceased and live births.

The conclusion The conclusion: While some studies have shown a positive association between ADHD medications and the risk of certain birth defects, other studies have found no connection and the majority of studies show a neutral or even slight negative effect. In all cases an in-depth evaluation of the benefits and risks should be conducted.

For many women with inattentive adhd medication uk and ADD, the decision to discontinue medication is difficult if not impossible. In an article recently published in Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of loneliness, and family conflict for patients with ADHD. A decrease in medication could also impact the ability to drive safely and perform work-related tasks, which are crucial aspects of everyday life for those with ADHD.

She suggests that women who are unsure whether to continue taking medication or stop it due to their pregnancy educate family members, coworkers and their friends about the condition, its effects on daily functioning, and the benefits of keeping the current treatment. Educating them can also help the woman feel supported when she is struggling with her decision. Certain medications can pass through the placenta. If the patient decides to stop taking her adhd anxiety medication medication while pregnant and breastfeeding, it's important to be aware that the medication may be transferred to her infant.

Risk of Birth Defects

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases there are concerns over the impact that these drugs could have on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. Utilizing two huge data sets, researchers were able to look at more than 4.3 million pregnancies to determine whether the use of stimulant medications increased the risk of birth defects. Although the risk overall is low, the researchers found that exposure in the first trimester to ADHD medications was associated with an increased risk of certain heart defects such as ventriculo-septal defect (VSD).

The authors of the study found no connection between the use of early medications and other congenital anomalies, such as facial clefting or club foot. The results are consistent with previous studies showing the presence of a small, but significant increase in the risk of cardiac malformations in women who started taking ADHD medications before the birth of their child. The risk grew during the latter part of pregnancy, when many women are forced to stop taking their medication.

Women who took ADHD medication in the first trimester were more likely to need a caesarean, have an insufficient Apgar after birth and have a baby who needed help breathing when they were born. The authors of the study could not remove bias in selection since they limited their study to women with no other medical conditions that might have contributed to the findings.

The researchers hope that their research will help inform the clinical decisions of doctors who treat pregnant women. The researchers recommend that while discussing benefits and risks are important, the decision about whether to continue or stop taking medication should be based on the severity of each woman's ADHD symptoms and the needs of the woman.

The authors also advise that while discontinuing the medications is an option, it isn't an option to consider due to the high prevalence of depression and other mental health issues in women who are pregnant or recently post-partum. Additionally, the research suggests that women who decide to stop taking their medications are more likely to experience a difficult time adapting to life without them after the baby's arrival.

Nursing

It can be a stressful experience to become a mother. Women with ADHD who have to deal with their symptoms while attending physician appointments as well as getting ready for the arrival of a baby and adjusting to new household routines are often faced with a number of difficulties. Many women choose to continue taking their ADHD medication during pregnancy.

The majority of stimulant drugs pass through breast milk in small amounts, therefore the risk to the infant who is breastfeeding is low. The rate of medication exposure will differ based on dosage the medication is administered, its frequency and the time of the day. In addition, individual medications enter the baby's system differently through the gastrointestinal tract as well as breast milk, and the effect of this on a newborn infant is not well understood.

Some doctors may decide to stop stimulant medication during a woman’s pregnancy due to the lack of research. It is a difficult decision for the mother, who must weigh the benefits of taking her medication as well as the potential risks to the fetus. Until more information is available, doctors should inquire with all pregnant patients about their history of ADHD and if they plan or are taking to take medication during the perinatal time.

Numerous studies have proven that women can continue taking their ADHD medication in a safe manner during pregnancy and while breast-feeding. In the end, an increasing number of patients choose to do so and, in consultation with their physician, they have discovered that the benefits of continuing their current medication far exceed any risk.

It's important for women with ADHD who are contemplating breastfeeding to seek out a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their prescriber and discuss the advantages and disadvantages of continued treatment, including non-pharmacological strategies. Psychoeducation is also required to help women with ADHD be aware of their symptoms and the root cause Learn about the available treatments and to reinforce existing strategies for coping. This should involve an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counselling should include discussion of a management plan for both the mother as well as the child, as well as monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.